Standout Papers
- Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV (2020)
- Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease (2018)
- GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses (2017)
Immediate Impact
5 by Nobel laureates 27 from Science/Nature 62 standout
Citing Papers
Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model
2024 StandoutScience
Direct radical functionalization of native sugars
2024 StandoutNature
Works of Michael O. Clarke being referenced
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
2020 Standout
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
2018 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Michael O. Clarke | 298 | 2144 | 284 | 523 | 499 | 17 | 2.9k | |
| Darius Babusis | 452 | 1683 | 179 | 345 | 533 | 45 | 2.7k | |
| Egor P. Tchesnokov | 545 | 2279 | 107 | 268 | 832 | 39 | 3.2k | |
| Danielle Porter | 483 | 3645 | 98 | 561 | 659 | 57 | 4.3k | |
| Qianyun Liu | 192 | 1839 | 94 | 319 | 710 | 42 | 3.3k | |
| Yingying Guo | 364 | 2706 | 63 | 522 | 1055 | 18 | 3.8k | |
| Philip V’kovski | 313 | 2042 | 92 | 222 | 846 | 18 | 3.0k | |
| Silvio Steiner | 173 | 1574 | 88 | 219 | 716 | 10 | 2.4k | |
| Yuanyuan Zhang | 307 | 2822 | 65 | 543 | 993 | 38 | 3.7k | |
| Dmitry Penzar | 286 | 3370 | 82 | 690 | 853 | 16 | 4.9k | |
| Alison Hogg | 290 | 1104 | 144 | 295 | 532 | 33 | 2.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...